Prospective comparison of infrainguinal bypass grafting in patients with and without antiphospholipid antibodies

R. W. Lee, Jr Taylor, G. J. Landry, S. H. Goodnight, G. L. Moneta, J. M. Edwards, R. A. Yeager, J. M. Porter, D. P. Flanigan, W. C. Krupski, V. M. Bernhard, E. J. Harris, J. Peck, D. B. Roos, Jr Strandness, J. D. Baker, A. D. Whittemore, Jr Tawes

    Research output: Contribution to journalArticle

    27 Scopus citations

    Abstract

    Purpose: The antiphospholipid antibodies (APL)-anticardiolipin antibodies (ACL) and lupus anticoagulant (LA)-are widely believed to be associated with decreased lower extremity bypass graft patency rates. To date, no prospective cohort study has confirmed this assumption. A prospective comparison of the result of infrainguinal revascularization procedures performed since 1990 in patients with and without APL forms the basis of this report. Methods: Patients who underwent elective infrainguinal bypass procedures from 1990 to 1994 were evaluated for hypercoagulable states (ACL, LA, protein C, protein S, and antithrombin III). Patient data were prospectively entered in a computerized vascular registry, and postoperative follow-up was maintained for life. Graft patency, limb salvage, and patient survival rates were calculated by life-table methods. Results: Three hundred twenty-seven lower extremity bypass grafting procedures were performed in 262 patients. APLs were present in 83 patients (32%); 70 patients (84%) had ACLs only, 11 patients (13%) had LA only, and two patients (3%) had both ACLs and LA. There was no significant difference between APL positive and APL- negative patients with respect to demographics, associated medical conditions, indication for operations, and type of procedures performed. More patients who had APLs had warfarin treatment after surgery (43% vs 24%, p = 0.002). Life table 4-year primary patency rates showed minimal difference (APL-positive, 43%; APL-negative, 59%; p = 0.087), and no significant difference was noted in assisted primary patency rates (APL positive, 72%; APL negative, 73%; p = NS), limb salvage rates (APL positive, 79%; APL negative, 88%; p = NS), and patient survival rates (APL positive, 67%; APL negative, 66%; p = NS). Conclusions: APLs were found in a surprising one third of the patients who underwent leg bypass grafting procedures. The majority of APLs identified were ACLs (87%). There was minimal difference in graft primary patency rates, and no difference in assisted primary patency, limb salvage, and survival rates between patients with and without APLs who underwent leg bypass grafting procedures. The extreme morbidity rate associated with APLs in previous reports is not confirmed by this prospective study. APLs should not be regarded as a contraindication to indicated leg bypass grafting procedures.

    Original languageEnglish (US)
    Pages (from-to)524-533
    Number of pages10
    JournalJournal of vascular surgery
    Volume24
    Issue number4
    DOIs
    StatePublished - Jan 1 1996

    ASJC Scopus subject areas

    • Surgery
    • Cardiology and Cardiovascular Medicine

    Fingerprint Dive into the research topics of 'Prospective comparison of infrainguinal bypass grafting in patients with and without antiphospholipid antibodies'. Together they form a unique fingerprint.

  • Cite this

    Lee, R. W., Taylor, J., Landry, G. J., Goodnight, S. H., Moneta, G. L., Edwards, J. M., Yeager, R. A., Porter, J. M., Flanigan, D. P., Krupski, W. C., Bernhard, V. M., Harris, E. J., Peck, J., Roos, D. B., Strandness, J., Baker, J. D., Whittemore, A. D., & Tawes, J. (1996). Prospective comparison of infrainguinal bypass grafting in patients with and without antiphospholipid antibodies. Journal of vascular surgery, 24(4), 524-533. https://doi.org/10.1016/S0741-5214(96)70068-X